you really see this dropping another 10% Jako? The amount of accumulation at these levels will hopefully ensure a strong rise in the share price once this market turns back to green
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%